Arena Lays Out Path Forward For Lorcaserin
This article was originally published in The Pink Sheet Daily
Executive Summary
Arena Pharmaceuticals and Japanese partner Eisai plan to resubmit an NDA for the controversial obesity drug lorcaserin by the end of 2011.